Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Pengo

Showing results (161-170 of 166) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 166 results.
Lancet (London, England)|February 26, 2008
Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial, M G Bousser, J Bouthier, et al.
Journal of Thrombosis and Haemostasis : JTH|July 7, 2018
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndromeK Legault, H Schunemann, C Hillis, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2017
International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plainA M H P van den Besselaar, V Chantarangkul, F Angeloni, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 18, 2018
Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective studyG R de Jesús, S Sciascia, D Andrade, et al.
Journal of Clinical Immunology|November 7, 2003
Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndromeY Shoenfeld, I Krause, F Kvapil, et al.
Clinical Pharmacology and Therapeutics|November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysisE Danese, M Montagnana, J A Johnson, et al.
Pageof 17

Showing results (161-170 of 166) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 166 results.
Lancet (London, England)|February 26, 2008
Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial, M G Bousser, J Bouthier, et al.
Journal of Thrombosis and Haemostasis : JTH|July 7, 2018
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndromeK Legault, H Schunemann, C Hillis, et al.
Journal of Thrombosis and Haemostasis : JTH|October 25, 2017
International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plainA M H P van den Besselaar, V Chantarangkul, F Angeloni, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 18, 2018
Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective studyG R de Jesús, S Sciascia, D Andrade, et al.
Journal of Clinical Immunology|November 7, 2003
Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndromeY Shoenfeld, I Krause, F Kvapil, et al.
Clinical Pharmacology and Therapeutics|November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysisE Danese, M Montagnana, J A Johnson, et al.
Pageof 17